Melanoma-Associated Deaths Rising Among Men Worldwide

Although malignant melanoma incidence has stabilized or declined in women, melanoma-associated mortality rates have risen among men throughout the world, according to new research presented at the 2018 National Cancer Research Institute Cancer Conference.

Skin cancer remains the most common form of cancer in the United States, with more than 65,000 cases of melanoma estimated in 2011, according to the CDC. Without additional prevention efforts, melanoma incidence is likely to increase over the next 15 years. Not only is the disease deadly, but melanoma is costly to treat as well. From 2011 to 2030, the CDC projects that the annual cost of treating patients with melanoma is expected to increase from $457 million to $1.6 billion.

The study includes worldwide data on deaths gathered by the World Health Organization across 33 countries with the most reliable data. The researchers aimed to analyze recent melanoma mortality rates across the world to identify patterns and understand whether new diagnosis, treatment, and prevention strategies have had any effect.

For the analysis, the researchers examined age-standardized death rates between 1985 and 2015, taking into account the demographics of each country. Overall, the data showed that melanoma death rates in men were rising in all but 1 country, the Czech Republic, where the researchers found a decrease in men’s melanoma death rates at an estimated annual percentage decrease of 0.7%. According to the study, the highest 3-year average death rates from 2013 to 2015 were found in Australia (5.72 per 100,000 men and 2.53 per 100,000 in women) and Slovenia (3.86 in men and 2.58 in women), with the lowest in Japan (0.24 in men and 0.18 in women).

Click to continue reading on Specialty Pharmacy Times.